Hetero

Hyderabad, India
VISIT WEBSITE
Hetero is one of India's leading generic pharmaceutical companies and the world's largest producer of anti-retroviral (ARV) drugs. Founded in 1993, the company has grown into a vertically integrated global powerhouse with a presence in over 145 countries. Hetero's business spans Active Pharmaceutical Ingredients (APIs), generic formulations, biosimilars, and custom pharmaceutical services (CDMO). The company is a critical player in global health, catering to 40% of the global demand for ARV drugs used in HIV/AIDS treatment. It operates over 36 state-of-the-art manufacturing facilities globally, many of which are approved by stringent regulatory bodies including the USFDA, EMA, and WHO. Hetero is also a major player in the biosimilars market through its dedicated arm, Hetero Biopharma, which focuses on oncology and immunology.
CLASSIFICATION
Company Type:Pharma
Industry:Pharmaceuticals
Sub-Industry:Generics, APIs, and Biosimilars
SIZE & FINANCIALS
Employees:10000+
Revenue:$2B-$3B
Founded:1993
Ownership:private
Status:operating
FUNDING
Stage:Late Stage
Total Raised:Unknown
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Multiple Biosimilars)
Modalities:Small molecule, Biosimilars (mAbs), Injectables
Active Trials:15
Trial Phases:Phase 1: 2 | Phase 2: 3 | Phase 3: 10
FDA Approvals:300
EMA Approvals:50
CORPORATE STRUCTURE
Parent Company:Hetero Group
Subsidiaries:Hetero Labs Limited, Hetero Biopharma Limited, Camber Pharmaceuticals (USA), Annora Pharma, Amarox Pharma
Key Partnerships:Medicines Patent Pool (MPP) for COVID-19 drugs, MS Pharma Group (MENA region localization), Clinton Health Access Initiative (CHAI)
COMPETITION
Position:Leader
Competitors:Dr. Reddy's Laboratories, Cipla, Sun Pharmaceutical, Laurus Labs, Aurobindo Pharma
LEADERSHIP
Key Executives:
Dr. B. Parthasaradhi Reddy - Chairman
Dr. B. Vamsi Krishna Reddy - Managing Director
Scientific Founders:Dr. B. Parthasaradhi Reddy
Board Members:Bandi Vamsikrishna, Venkatanarasa Reddy Attunuri, Sambi Reddy Jonnala
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Hetero. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.